APG Asset Management N.V. Increases Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

APG Asset Management N.V. lifted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 159.9% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 26,981 shares of the company’s stock after purchasing an additional 16,600 shares during the period. APG Asset Management N.V.’s holdings in Bath & Body Works were worth $983,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in BBWI. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Bath & Body Works by 28.1% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company’s stock worth $12,936,000 after acquiring an additional 56,764 shares during the period. Russell Investments Group Ltd. increased its stake in shares of Bath & Body Works by 46.9% in the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock worth $6,572,000 after purchasing an additional 41,995 shares in the last quarter. Vanguard Group Inc. raised its holdings in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after purchasing an additional 1,102,124 shares during the period. SG Americas Securities LLC lifted its position in Bath & Body Works by 968.1% during the first quarter. SG Americas Securities LLC now owns 190,758 shares of the company’s stock valued at $9,542,000 after purchasing an additional 172,898 shares in the last quarter. Finally, Keeley Teton Advisors LLC grew its holdings in Bath & Body Works by 262.9% during the fourth quarter. Keeley Teton Advisors LLC now owns 50,574 shares of the company’s stock valued at $2,183,000 after purchasing an additional 36,638 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI opened at $31.92 on Tuesday. The stock has a market capitalization of $7.13 billion, a price-to-earnings ratio of 8.23, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The business’s 50 day simple moving average is $31.74 and its 200-day simple moving average is $40.14.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.51%. Bath & Body Works’s dividend payout ratio is currently 20.62%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on BBWI. Morgan Stanley lowered their price objective on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. Bank of America lowered their price target on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Barclays decreased their price objective on shares of Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 29th. BMO Capital Markets restated an “outperform” rating and set a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Finally, The Goldman Sachs Group cut their price target on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Eight investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and a consensus target price of $42.35.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.